Altimmune, Inc.ALTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank21
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-67.83M
↓ 187% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-23.63M
Historical baseline
PeriodValueYoY Change
TTM$-67.83M+15.0%
2024$-79.85M-5.3%
2023$-75.81M-21.1%
2022$-62.59M+20.0%
2021$-78.24M-128.1%
2020$-34.31M-257.3%
2019$-9.60M-2.3%
2018$-9.39M+53.6%
2017$-20.21M-110.0%
2016$201.51M-